{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:14:30Z","timestamp":1791101670432,"version":"4.1.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1038\/ncpneph0076","type":"journal-article","created":{"date-parts":[[2006,5,16]],"date-time":"2006-05-16T17:16:06Z","timestamp":1147799766000},"page":"80-91","source":"Crossref","is-referenced-by-count":277,"title":["Drug-associated renal dysfunction and injury"],"prefix":"10.1038","volume":"2","author":[{"given":"Devasmita","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziauddin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpneph0076_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/01.ccx.0000145095.90327.f2","volume":"10","author":"WK Han","year":"2004","unstructured":"Han WK and Bonventre JV (2004) Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care 10: 476\u2013482","journal-title":"Curr Opin Crit Care"},{"key":"BFncpneph0076_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-4684-8240-9_16","volume":"212","author":"D Kleinknecht","year":"1987","unstructured":"Kleinknecht D et al. (1987) Drug-associated acute renal failure: a prospective collaborative study of 81 biopsied patients. Adv Exp Med Biol 212: 125\u2013128","journal-title":"Adv Exp Med Biol"},{"key":"BFncpneph0076_CR3","volume-title":"Antibiotic and Immunosupression-Related Renal Failure","author":"GJ Kaloyandes","year":"2001","unstructured":"Kaloyandes GJ et al. (2001) Antibiotic and Immunosupression-Related Renal Failure. Philadelphia: Lippincott, Williams & Wilkins"},{"key":"BFncpneph0076_CR4","first-page":"228","volume":"15","author":"D Kleinknecht","year":"1995","unstructured":"Kleinknecht D (1995) Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs. Semin Nephrol 15: 228\u2013235","journal-title":"Semin Nephrol"},{"key":"BFncpneph0076_CR5","first-page":"1277","volume":"24","author":"AV Klinkhoff","year":"1997","unstructured":"Klinkhoff AV and Teufel A (1997) Reinstitution of gold after gold induced proteinuria. J Rheumatol 24: 1277\u20131279","journal-title":"J Rheumatol"},{"key":"BFncpneph0076_CR6","first-page":"557","volume":"19","author":"CS Wilcox","year":"1999","unstructured":"Wilcox CS (1999) Metabolic and adverse effects of diuretics. Semin Nephrol 19: 557\u2013568","journal-title":"Semin Nephrol"},{"key":"BFncpneph0076_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000047397","volume":"96","author":"DH Ellison","year":"2001","unstructured":"Ellison DH (2001) Diuretic therapy and resistance in congestive heart failure. Cardiology 96: 132\u2013143","journal-title":"Cardiology"},{"key":"BFncpneph0076_CR8","first-page":"408","volume":"11","author":"D Fliser","year":"1996","unstructured":"Fliser D (1996) Loop diuretics and thiazides\u2014the case for their combination in chronic renal failure. Nephrol Dial Transplant 11: 408\u2013410","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0076_CR9","first-page":"938","volume":"114","author":"A Sandhofer","year":"2002","unstructured":"Sandhofer A et al. (2002) Severe electrolyte disturbances and renal failure in elderly patients with combined diuretic therapy including xipamid. Wien Klin Wochenschr 114: 938\u2013942","journal-title":"Wien Klin Wochenschr"},{"issue":"Suppl","key":"BFncpneph0076_CR10","first-page":"S33","volume":"59","author":"WN Suki","year":"1997","unstructured":"Suki WN (1997) Use of diuretics in chronic renal failure. Kidney Int 59 (Suppl): S33\u2013S35","journal-title":"Kidney Int"},{"key":"BFncpneph0076_CR11","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3171\/jns.2004.100.3.0376","volume":"100","author":"J Cruz","year":"2004","unstructured":"Cruz J et al. (2004) Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial. J Neurosurg 100: 376\u2013383","journal-title":"J Neurosurg"},{"key":"BFncpneph0076_CR12","first-page":"632","volume":"52","author":"P Ejaz","year":"2004","unstructured":"Ejaz P et al. (2004) NSAIDs and kidney. J Assoc Physicians India 52: 632\u2013640","journal-title":"J Assoc Physicians India"},{"key":"BFncpneph0076_CR13","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1097\/01.TP.0000121196.71904.E0","volume":"77","author":"BJ Nankivell","year":"2004","unstructured":"Nankivell BJ et al. (2004) Oral cyclosporine but not tacrolimus reduces renal transplant blood flow. Transplantation 77: 1457\u20131459","journal-title":"Transplantation"},{"key":"BFncpneph0076_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/00075198-200112000-00003","volume":"7","author":"AJ Olyaei","year":"2001","unstructured":"Olyaei AJ et al. (2001) Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care 7: 384\u2013389","journal-title":"Curr Opin Crit Care"},{"key":"BFncpneph0076_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1001\/archinte.1980.00330160091033","volume":"140","author":"LS Fang","year":"1980","unstructured":"Fang LS et al. (1980) Low fractional excretion of sodium with contrast media-induced acute renal failure. Arch Intern Med 140: 531\u2013533","journal-title":"Arch Intern Med"},{"key":"BFncpneph0076_CR16","first-page":"54","volume":"98","author":"D Van Buren","year":"1985","unstructured":"Van Buren D et al. (1985) De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine. Surgery 98: 54\u201362","journal-title":"Surgery"},{"key":"BFncpneph0076_CR17","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.transproceed.2005.02.112","volume":"37","author":"A Bren","year":"2005","unstructured":"Bren A et al. (2005) Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy. Transplant Proc 37: 1889\u20131891","journal-title":"Transplant Proc"},{"key":"BFncpneph0076_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1432-2277.2000.tb01023.x","volume":"13","author":"KA Abraham","year":"2000","unstructured":"Abraham KA et al. (2000) Hemolytic\u2013uremic syndrome in association with both cyclosporine and tacrolimus. Transpl Int 13: 443\u2013447","journal-title":"Transpl Int"},{"key":"BFncpneph0076_CR19","first-page":"580","volume":"16","author":"CC Lin","year":"2003","unstructured":"Lin CC et al. (2003) Tacrolimus-associated hemolytic uremic syndrome: a case analysis. J Nephrol 16: 580\u2013585","journal-title":"J Nephrol"},{"key":"BFncpneph0076_CR20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/0140-6736(92)91897-H","volume":"339","author":"D Abramowicz","year":"1992","unstructured":"Abramowicz D et al. (1992) Induction of thromboses within renal grafts by high-dose prophylactic OKT3. Lancet 339: 777\u2013778","journal-title":"Lancet"},{"key":"BFncpneph0076_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/00062752-200109000-00004","volume":"8","author":"PJ Medina","year":"2001","unstructured":"Medina PJ et al. (2001) Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol 8: 286\u2013293","journal-title":"Curr Opin Hematol"},{"key":"BFncpneph0076_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00007890-200008150-00029","volume":"70","author":"S Chinnakotla","year":"2000","unstructured":"Chinnakotla S et al. (2000) Clopidogrel-associated thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome in a kidney\/pancreas transplant recipient. Transplantation 70: 550\u2013552","journal-title":"Transplantation"},{"key":"BFncpneph0076_CR23","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","volume":"45","author":"H Izzedine","year":"2005","unstructured":"Izzedine H et al. (2005) Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 45: 804\u2013817","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0076_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.7326\/0003-4819-101-1-41","volume":"101","author":"AM Jackson","year":"1984","unstructured":"Jackson AM et al. (1984) Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy. Ann Intern Med 101: 41\u201344","journal-title":"Ann Intern Med"},{"key":"BFncpneph0076_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0272-6386(85)80035-4","volume":"6","author":"L Giroux","year":"1985","unstructured":"Giroux L et al. (1985) Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases. Am J Kidney Dis 6: 28\u201339","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0076_CR26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2165\/00002018-200124070-00002","volume":"24","author":"R Pisoni","year":"2001","unstructured":"Pisoni R et al. (2001) Drug-induced thrombotic microangiopathy: incidence, prevention and management. Drug Saf 24: 491\u2013501","journal-title":"Drug Saf"},{"key":"BFncpneph0076_CR27","first-page":"1256","volume":"23","author":"KK Venkat","year":"1991","unstructured":"Venkat KK et al. (1991) Reversal of cyclosporine-associated hemolytic\u2013uremic syndrome by plasma exchange with fresh-frozen plasma replacement in renal transplant recipients. Transplant Proc 23: 1256\u20131257","journal-title":"Transplant Proc"},{"key":"BFncpneph0076_CR28","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/00007890-199902270-00009","volume":"67","author":"HM Trimarchi","year":"1999","unstructured":"Trimarchi HM et al. (1999) FK506-associated thrombotic microangiopathy: report of two cases and review of the literature. Transplantation 67: 539\u2013544","journal-title":"Transplantation"},{"key":"BFncpneph0076_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/1097-0142(19850101)55:1<51::AID-CNCR2820550109>3.0.CO;2-D","volume":"55","author":"TM Price","year":"1985","unstructured":"Price TM et al. (1985) Renal failure and hemolytic anemia associated with mitomycin C. A case report. Cancer 55: 51\u201356","journal-title":"Cancer"},{"key":"BFncpneph0076_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1159\/000185333","volume":"51","author":"G Garibotto","year":"1989","unstructured":"Garibotto G et al. (1989) Successful treatment of mitomycin C-associated hemolytic uremic syndrome by plasmapheresis. Nephron 51: 409\u2013412","journal-title":"Nephron"},{"key":"BFncpneph0076_CR31","first-page":"367","volume":"8","author":"C Ponticelli","year":"1977","unstructured":"Ponticelli C et al. (1977) Late recovery of renal function in a woman with the hemolytic uremic syndrome. Clin Nephrol 8: 367\u2013370","journal-title":"Clin Nephrol"},{"key":"BFncpneph0076_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S0140-6736(81)91943-7","volume":"1","author":"D Hauglustaine","year":"1981","unstructured":"Hauglustaine D et al. (1981) Oestrogen containing oral contraceptives, decreased prostacyclin production, and haemolytic uraemic syndrome. Lancet 1: 328\u2013329","journal-title":"Lancet"},{"key":"BFncpneph0076_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0889-8588(18)30514-8","volume":"4","author":"P Ruggenenti","year":"1990","unstructured":"Ruggenenti P and Remuzzi G (1990) Thrombotic thrombocytopenic purpura and related disorders. Hematol Oncol Clin North Am 4: 219\u2013241","journal-title":"Hematol Oncol Clin North Am"},{"key":"BFncpneph0076_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0272-6386(12)80449-5","volume":"19","author":"JS Berns","year":"1992","unstructured":"Berns JS et al. (1992) Inherited hemolytic uremic syndrome in adults. Am J Kidney Dis 19: 331\u2013334","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0076_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/00002018-200124010-00003","volume":"24","author":"PE Kintzel","year":"2001","unstructured":"Kintzel PE (2001) Anticancer drug-induced kidney disorders. Drug Saf 24: 19\u201338","journal-title":"Drug Saf"},{"key":"BFncpneph0076_CR36","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.1053\/ajkd.2002.35758","volume":"40","author":"RB Walter","year":"2002","unstructured":"Walter RB et al. (2002) Gemcitabine-associated hemolytic\u2013uremic syndrome. Am J Kidney Dis 40: E16","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0076_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/01.SMJ.0000152754.12363.45","volume":"98","author":"WA Hitti","year":"2005","unstructured":"Hitti WA and Anderson J (2005) Cholesterol emboli-induced renal failure and gastric ulcer after thrombolytic therapy. South Med J 98: 235\u2013237","journal-title":"South Med J"},{"key":"BFncpneph0076_CR38","first-page":"428","volume":"9","author":"S Ben-Chitrit","year":"1994","unstructured":"Ben-Chitrit S et al. (1994) Cholesterol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasminogen activator. Nephrol Dial Transplant 9: 428\u2013430","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0076_CR39","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1161\/01.CIR.30.4.611","volume":"30","author":"RS Eliot","year":"1964","unstructured":"Eliot RS et al. (1964) Atheromatous Embolism. Circulation 30: 611\u2013618","journal-title":"Circulation"},{"key":"BFncpneph0076_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1046\/j.1365-2133.2002.04611.x","volume":"146","author":"M Pennington","year":"2002","unstructured":"Pennington M et al. (2002) Cholesterol embolization syndrome: cutaneous histopathological features and the variable onset of symptoms in patients with different risk factors. Br J Dermatol 146: 511\u2013517","journal-title":"Br J Dermatol"},{"key":"BFncpneph0076_CR41","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1177\/000331978703801007","volume":"38","author":"MJ Fine","year":"1987","unstructured":"Fine MJ et al. (1987) Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology 38: 769\u2013784","journal-title":"Angiology"},{"key":"BFncpneph0076_CR42","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0140-6736(05)70238-5","volume":"365","author":"N Lameire","year":"2005","unstructured":"Lameire N et al. (2005) Acute renal failure. Lancet 365: 417\u2013430","journal-title":"Lancet"},{"key":"BFncpneph0076_CR43","volume-title":"Pathophysiology of Ischemic Acute Renal Injury","author":"CL Edelstein","year":"2001","unstructured":"Edelstein CL and Schrier R (2001) Pathophysiology of Ischemic Acute Renal Injury. Philadelphia: Lippincott, Williams & Wilkins"},{"issue":"Suppl","key":"BFncpneph0076_CR44","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1111\/j.1523-1755.2005.09425.x","volume":"67","author":"WL Henrich","year":"2005","unstructured":"Henrich WL (2005) Nephrotoxicity of several newer agents. Kidney Int 67 (Suppl): S107\u2013S109","journal-title":"Kidney Int"},{"key":"BFncpneph0076_CR45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1681\/ASN.V113383","volume":"11","author":"ES Ho","year":"2000","unstructured":"Ho ES et al. (2000) Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J Am Soc Nephrol 11: 383\u2013393","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0076_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2133\/dmpk.19.159","volume":"19","author":"J Nagai","year":"2004","unstructured":"Nagai J and Takano M (2004) Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. Drug Metab Pharmacokinet 19: 159\u2013170","journal-title":"Drug Metab Pharmacokinet"},{"key":"BFncpneph0076_CR47","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/ki.1980.175","volume":"18","author":"GJ Kaloyanides","year":"1980","unstructured":"Kaloyanides GJ and Pastoriza-Munoz E (1980) Aminoglycoside nephrotoxicity. Kidney Int 18: 571\u2013582","journal-title":"Kidney Int"},{"key":"BFncpneph0076_CR48","volume-title":"Toxic Nephropathy","author":"RE Cronin","year":"1996","unstructured":"Cronin RE and Henrich WL (1996) Toxic Nephropathy. Philadelphia: WB Saunders"},{"key":"BFncpneph0076_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-0689-4_39","volume-title":"Toxic Nephropathies","author":"J Maher","year":"1991","unstructured":"Maher J (1991) Toxic Nephropathies. Boston: Kluwer Academic Publishers"},{"key":"BFncpneph0076_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000181606","volume":"23","author":"R Patel","year":"1979","unstructured":"Patel R and Savage A (1979) Symptomatic hypomagnesemia associated with gentamicin therapy. Nephron 23: 50\u201352","journal-title":"Nephron"},{"key":"BFncpneph0076_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000086055","volume":"148","author":"T Taguchi","year":"2005","unstructured":"Taguchi T et al. (2005) Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 148: 107\u2013121","journal-title":"Contrib Nephrol"},{"key":"BFncpneph0076_CR52","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00204-005-0648-6","volume":"79","author":"T Uehara","year":"2005","unstructured":"Uehara T et al. (2005) Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats. Arch Toxicol 79: 451\u2013460","journal-title":"Arch Toxicol"},{"key":"BFncpneph0076_CR53","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1046\/j.1523-1755.2003.00071.x","volume":"64","author":"GS Markowitz","year":"2003","unstructured":"Markowitz GS et al. (2003) Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int 64: 281\u2013289","journal-title":"Kidney Int"},{"key":"BFncpneph0076_CR54","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s002239900606","volume":"64","author":"E Hiroi-Furuya","year":"1999","unstructured":"Hiroi-Furuya E et al. (1999) Etidronate (EHDP) inhibits osteoclastic-bone resorption, promotes apoptosis and disrupts actin rings in isolate-mature osteoclasts. Calcif Tissue Int 64: 219\u2013223","journal-title":"Calcif Tissue Int"},{"key":"BFncpneph0076_CR55","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1681\/ASN.V1261164","volume":"12","author":"G Markowitz","year":"2001","unstructured":"Markowitz G et al. (2001) Collapsing focal segmental glomerulosclerosis following treatment with high dose pamidronate. J Am Soc Nephrol 12: 1164\u20131172","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0076_CR56","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.semarthrit.2004.06.003","volume":"34","author":"H Orbach","year":"2004","unstructured":"Orbach H et al. (2004) Intravenous immunoglobulin and the kidney\u2014a two-edged sword. Semin Arthritis Rheum 34: 593\u2013601","journal-title":"Semin Arthritis Rheum"},{"key":"BFncpneph0076_CR57","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000326232","volume":"44","author":"M Khalil","year":"2000","unstructured":"Khalil M et al. (2000) Macrophagelike vacuolated renal tubular cells in the urine of a male with osmotic nephrosis associated with intravenous immunoglobulin therapy: a case report. Acta Cytol 44: 86\u201390","journal-title":"Acta Cytol"},{"key":"BFncpneph0076_CR58","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1681\/ASN.V861028","volume":"8","author":"P Visweswaran","year":"1997","unstructured":"Visweswaran P et al. (1997) Mannitol-induced acute renal failure. J Am Soc Nephrol 8: 1028\u20131033","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0076_CR59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3109\/08860229709026293","volume":"19","author":"R Ferraboli","year":"1997","unstructured":"Ferraboli R et al. (1997) Anuric acute renal failure caused by dextran 40 administration. Ren Fail 19: 303\u2013306","journal-title":"Ren Fail"},{"key":"BFncpneph0076_CR60","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/S0272-6386(04)01098-4","volume":"44","author":"U Erdbruegger","year":"2004","unstructured":"Erdbruegger U et al. (2004) Quiz page: tubular epithelial injury consistent with osmotic nephrosis. Am J Kidney Dis 44: e1","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0076_CR61","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0002-9343(01)00873-7","volume":"111","author":"A De Labarthe","year":"2001","unstructured":"De Labarthe A et al. (2001) Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. Am J Med 111: 417\u2013418","journal-title":"Am J Med"},{"key":"BFncpneph0076_CR62","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0272-6386(96)90505-3","volume":"28","author":"S Hansen-Schmidt","year":"1996","unstructured":"Hansen-Schmidt S et al. (1996) Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis. Am J Kidney Dis 28: 451\u2013453","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0076_CR63","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000054216","volume":"24","author":"J Gossmann","year":"2001","unstructured":"Gossmann J et al. (2001) Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide? Kidney Blood Press Res 24: 111\u2013115","journal-title":"Kidney Blood Press Res"},{"key":"BFncpneph0076_CR64","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/ki.1996.417","volume":"50","author":"TF Andoh","year":"1996","unstructured":"Andoh TF et al. (1996) Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int 50: 1110\u20131117","journal-title":"Kidney Int"},{"key":"BFncpneph0076_CR65","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1586\/14787210.3.2.167","volume":"3","author":"WJ Gibbs","year":"2005","unstructured":"Gibbs WJ et al. (2005) Liposomal amphotericin B: clinical experience and perspectives. Expert Rev Anti Infect Ther 3: 167\u2013181","journal-title":"Expert Rev Anti Infect Ther"},{"key":"BFncpneph0076_CR66","doi-asserted-by":"publisher","first-page":"22E","DOI":"10.1016\/0002-9149(89)90730-3","volume":"64","author":"GA Porter","year":"1989","unstructured":"Porter GA (1989) Contrast-associated nephropathy. Am J Cardiol 64: 22E\u201326E","journal-title":"Am J Cardiol"},{"key":"BFncpneph0076_CR67","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1001\/archinte.162.3.329","volume":"162","author":"C Mueller","year":"2002","unstructured":"Mueller C et al. (2002) Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162: 329\u2013336","journal-title":"Arch Intern Med"},{"key":"BFncpneph0076_CR68","first-page":"49","volume":"53","author":"C Briguori","year":"2005","unstructured":"Briguori C et al. (2005) New pharmacological protocols to prevent or reduce contrast media nephropathy. Minerva Cardioangiol 53: 49\u201358","journal-title":"Minerva Cardioangiol"},{"key":"BFncpneph0076_CR69","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1056\/NEJM200007203430304","volume":"343","author":"M Tepel","year":"2000","unstructured":"Tepel M et al. (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343: 180\u2013184","journal-title":"N Engl J Med"},{"key":"BFncpneph0076_CR70","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1001\/jama.290.17.2284","volume":"290","author":"GW Stone","year":"2003","unstructured":"Stone GW et al. (2003) Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 290: 2284\u20132291","journal-title":"JAMA"},{"key":"BFncpneph0076_CR71","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0002-9343(01)00983-4","volume":"111","author":"B Vogt","year":"2001","unstructured":"Vogt B et al. (2001) Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 111: 692\u2013698","journal-title":"Am J Med"},{"key":"BFncpneph0076_CR72","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa023204","volume":"349","author":"G Marenzi","year":"2003","unstructured":"Marenzi G et al. (2003) The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 349: 1333\u20131340","journal-title":"N Engl J Med"},{"key":"BFncpneph0076_CR73","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJM200402193500816","volume":"350","author":"K Kancha","year":"2004","unstructured":"Kancha K et al. (2004) Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy. N Engl J Med 350: 836\u2013838; author reply 836\u2013838","journal-title":"N Engl J Med"},{"key":"BFncpneph0076_CR74","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJM200402193500816","volume":"350","author":"JP Forman","year":"2004","unstructured":"Forman JP (2004) Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy. N Engl J Med 350: 836\u2013838; author reply 836\u2013838","journal-title":"N Engl J Med"},{"key":"BFncpneph0076_CR75","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0741-5214(03)00315-X","volume":"38","author":"AD Sam II","year":"2003","unstructured":"Sam AD II et al. (2003) Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg 38: 313\u2013318","journal-title":"J Vasc Surg"},{"key":"BFncpneph0076_CR76","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1046\/j.1523-1755.2001.060002804.x","volume":"60","author":"J Rossert","year":"2001","unstructured":"Rossert J (2001) Drug-induced acute interstitial nephritis. Kidney Int 60: 804\u2013817","journal-title":"Kidney Int"},{"key":"BFncpneph0076_CR77","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1086\/313475","volume":"29","author":"P Baylor","year":"1999","unstructured":"Baylor P and Williams K (1999) Interstitial nephritis, thrombocytopenia, hepatitis, and elevated serum amylase levels in a patient receiving clarithromycin therapy. Clin Infect Dis 29: 1350\u20131351","journal-title":"Clin Infect Dis"},{"key":"BFncpneph0076_CR78","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1053\/j.ajkd.2004.04.045","volume":"44","author":"M Tintillier","year":"2004","unstructured":"Tintillier M et al. (2004) Telithromycin-induced acute interstitial nephritis: a first case report. Am J Kidney Dis 44: e25\u2013e27","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0076_CR79","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/art.20543","volume":"51","author":"A Szalat","year":"2004","unstructured":"Szalat A et al. (2004) Acute renal failure and interstitial nephritis in a patient treated with rofecoxib: case report and review of the literature. Arthritis Rheum 51: 670\u2013673","journal-title":"Arthritis Rheum"},{"key":"BFncpneph0076_CR80","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1345\/aph.1D085","volume":"38","author":"A Ra","year":"2004","unstructured":"Ra A and Tobe SW (2004) Acute interstitial nephritis due to pantoprazole. Ann Pharmacother 38: 41\u201345","journal-title":"Ann Pharmacother"},{"key":"BFncpneph0076_CR81","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1093\/ndt\/gfh485","volume":"19","author":"MR Clarkson","year":"2004","unstructured":"Clarkson MR et al. (2004) Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant 19: 2778\u20132783","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0076_CR82","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1056\/NEJM198403013100905","volume":"310","author":"DM Clive","year":"1984","unstructured":"Clive DM and Stoff JS (1984) Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 310: 563\u2013572","journal-title":"N Engl J Med"},{"key":"BFncpneph0076_CR83","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1056\/NEJM199902043400515","volume":"340","author":"H Hanabusa","year":"1999","unstructured":"Hanabusa H et al. (1999) Renal atrophy associated with long-term treatment with indinavir. N Engl J Med 340: 392\u2013393","journal-title":"N Engl J Med"},{"key":"BFncpneph0076_CR84","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/ndt\/13.3.750","volume":"13","author":"F Martinez","year":"1998","unstructured":"Martinez F et al. (1998) Indinavir crystal deposits associated with tubulointerstitial nephropathy. Nephrol Dial Transplant 13: 750\u2013753","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0076_CR85","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2165\/00003495-200464030-00003","volume":"64","author":"M Daudon","year":"2004","unstructured":"Daudon M and Jungers P (2004) Drug-induced renal calculi: epidemiology, prevention and management. Drugs 64: 245\u2013275","journal-title":"Drugs"},{"key":"BFncpneph0076_CR86","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1681\/ASN.V84684","volume":"8","author":"TM Demko","year":"1997","unstructured":"Demko TM et al. (1997) Obstructive nephropathy as a result of retroperitoneal fibrosis: a review of its pathogenesis and associations. J Am Soc Nephrol 8: 684\u2013688","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0076_CR87","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S0022-5347(17)41059-7","volume":"141","author":"VV Waters","year":"1989","unstructured":"Waters VV (1989) Hydralazine, hydrochlorothiazide and ampicillin associated with retroperitoneal fibrosis: case report. J Urol 141: 936\u2013937","journal-title":"J Urol"},{"key":"BFncpneph0076_CR88","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0140-6736(75)92733-6","volume":"2","author":"BM Iversen","year":"1975","unstructured":"Iversen BM et al. (1975) Retroperitoneal fibrosis during treatment with methydopa. Lancet 2: 302\u2013304","journal-title":"Lancet"},{"key":"BFncpneph0076_CR89","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/BF02082717","volume":"18","author":"L Damstrup","year":"1986","unstructured":"Damstrup L and Jensen TT (1986) Retroperitoneal fibrosis after long-term daily use of ergotamine. Int Urol Nephrol 18: 299\u2013301","journal-title":"Int Urol Nephrol"},{"key":"BFncpneph0076_CR90","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJM199412223312502","volume":"331","author":"TV Perneger","year":"1994","unstructured":"Perneger TV et al. (1994) Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 331: 1675\u20131679","journal-title":"N Engl J Med"},{"key":"BFncpneph0076_CR91","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/ki.1978.11","volume":"13","author":"RS Nanra","year":"1978","unstructured":"Nanra RS et al. (1978) Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlations in Australia. Kidney Int 13: 79\u201392","journal-title":"Kidney Int"},{"key":"BFncpneph0076_CR92","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ki.1978.4","volume":"13","author":"FJ Gloor","year":"1978","unstructured":"Gloor FJ (1978) Changing concepts in pathogenesis and morphology of analgesic nephropathy as seen in Europe. Kidney Int 13: 27\u201333","journal-title":"Kidney Int"},{"key":"BFncpneph0076_CR93","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ki.1980.29","volume":"17","author":"P Kincaid-Smith","year":"1980","unstructured":"Kincaid-Smith P (1980) Analgesic abuse and the kidney. Kidney Int 17: 250\u2013260","journal-title":"Kidney Int"},{"key":"BFncpneph0076_CR94","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/ki.1985.172","volume":"28","author":"PH Bach","year":"1985","unstructured":"Bach PH and Hardy TL (1985) Relevance of animal models to analgesic-associated renal papillary necrosis in humans. Kidney Int 28: 605\u2013613","journal-title":"Kidney Int"},{"key":"BFncpneph0076_CR95","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1001\/archinte.163.1.114","volume":"163","author":"L Akhund","year":"2003","unstructured":"Akhund L et al. (2003) Celecoxib-related renal papillary necrosis. Arch Intern Med 163: 114\u2013115","journal-title":"Arch Intern Med"},{"key":"BFncpneph0076_CR96","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/ki.1981.192","volume":"20","author":"I Blohme","year":"1981","unstructured":"Blohme I and Johansson S (1981) Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy. Kidney Int 20: 671\u2013675","journal-title":"Kidney Int"},{"key":"BFncpneph0076_CR97","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/ki.1986.154","volume":"30","author":"M McCredie","year":"1986","unstructured":"McCredie M et al. (1986) Phenacetin and papillary necrosis: independent risk factors for renal pelvic cancer. Kidney Int 30: 81\u201384","journal-title":"Kidney Int"},{"key":"BFncpneph0076_CR98","doi-asserted-by":"publisher","first-page":"229S","DOI":"10.1016\/j.transproceed.2004.01.021","volume":"36","author":"A Busauschina","year":"2004","unstructured":"Busauschina A et al. (2004) Cyclosporine nephrotoxicity. Transplant Proc 36: 229S\u2013233S","journal-title":"Transplant Proc"},{"key":"BFncpneph0076_CR99","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1681\/ASN.V1181439","volume":"11","author":"GS Markowitz","year":"2000","unstructured":"Markowitz GS et al. (2000) Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 11: 1439\u20131448","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0076_CR100","doi-asserted-by":"publisher","first-page":"F1276","DOI":"10.1152\/ajprenal.00305.2004","volume":"288","author":"A Rojek","year":"2005","unstructured":"Rojek A et al. (2005) Altered expression of selected genes in kidney of rats with lithium-induced NDI. Am J Physiol Renal Physiol 288: F1276\u20131289","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFncpneph0076_CR101","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0002-9343(71)90244-0","volume":"51","author":"HO Cutting","year":"1971","unstructured":"Cutting HO (1971) Inappropriate secretion of antidiuretic hormone secondary to vincristine therapy. Am J Med 51: 269\u2013271","journal-title":"Am J Med"},{"key":"BFncpneph0076_CR102","first-page":"245","volume":"185","author":"TH Steele","year":"1973","unstructured":"Steele TH et al. (1973) Antidiuretic response to cyclophosphamide in man. J Pharmacol Exp Ther 185: 245\u2013253","journal-title":"J Pharmacol Exp Ther"},{"key":"BFncpneph0076_CR103","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/bmj.1.5687.26","volume":"1","author":"OM Edwards","year":"1970","unstructured":"Edwards OM et al. (1970) Azotaemia aggravated by tetracycline. Br Med J 1: 26\u201327","journal-title":"Br Med J"}],"container-title":["Nature Clinical Practice Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0076","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:11:19Z","timestamp":1684440679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneph0076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":103,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["BFncpneph0076"],"URL":"https:\/\/doi.org\/10.1038\/ncpneph0076","relation":{},"ISSN":["1745-8323","1745-8331"],"issn-type":[{"value":"1745-8323","type":"print"},{"value":"1745-8331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}